Realistic illustration of an Indian man holding alcohol and chewing tobacco, with overlaid stats on buccal mucosa cancer risk from a new study.
Àwòrán tí AI ṣe

Study in India links even one daily drink to higher buccal mucosa cancer risk, especially with chewing tobacco

Àwòrán tí AI ṣe
Ti ṣayẹwo fun ododo

A large case-control study in India reports that drinking about one standard drink a day (roughly 9 grams of alcohol) is associated with an estimated 50% higher risk of buccal mucosa cancer. The researchers also estimate that the combination of alcohol use and chewing tobacco may account for about 62% of cases nationally, with the strongest association seen among people who mainly consumed locally brewed alcoholic beverages.

A large comparative, multicentre case-control study published online in the open-access journal BMJ Global Health found that even low levels of alcohol consumption were associated with a higher risk of buccal mucosa cancer—the most common form of mouth cancer in India.

The researchers compared 1,803 men diagnosed with buccal mucosa cancer with 1,903 controls without the disease. Participants were recruited from five study centres between 2010 and 2021. Most participants were aged 35 to 54, and nearly 46% of cases occurred among people aged 25 to 45, according to the report.

Participants provided detailed histories of alcohol use, including the types of drinks consumed. The study recorded 11 internationally recognised beverages—such as beer, whisky, vodka, rum and “breezers” (flavoured alcoholic drinks)—and 30 locally brewed drinks, including apong, bangla, chulli, desi daru and mahua.

Among the cancer cases, 781 reported drinking alcohol and 1,019 did not. In the control group, 481 reported drinking and 1,420 did not. On average, those with cancer reported a longer history of tobacco use—about 21 years compared with roughly 18 years among controls—and they also reported higher daily alcohol intake, nearly 37 grams compared with about 29 grams.

Compared with people who did not drink, alcohol users had an estimated 68% higher risk of buccal mucosa cancer. The estimated risk increase was 72% among people who mainly consumed internationally recognised drinks and 87% among those who mainly consumed locally brewed alcohol.

The analysis suggested that there was no clear “safe” threshold: drinking under 2 grams of beer per day was still associated with elevated risk, while consuming about 9 grams of alcohol per day—roughly one standard drink—was associated with an estimated 50% increase.

The researchers reported the largest effect when alcohol use overlapped with chewing tobacco. Concurrent exposure was associated with more than a fourfold increase in risk, and the team estimated that the interaction between alcohol and chewing tobacco could account for about 62% of buccal mucosa cancer cases in India. They also estimated that alcohol alone accounts for nearly 11.5% of buccal mucosa cancer cases nationally, rising to about 14% in some high-prevalence states, including Meghalaya, Assam and Madhya Pradesh.

The report noted that mouth cancer is the second most common cancer in India, with an estimated 143,759 new diagnoses and 79,979 deaths each year. Incidence rates are reported to be just under 15 per 100,000 Indian men. Survival outcomes remain poor, with about 43% of patients living at least five years after diagnosis.

As a possible explanation, the researchers suggested that ethanol may alter the fat content of the mouth’s inner lining, increasing permeability and susceptibility to carcinogens present in chewing tobacco products.

The study also flagged concerns about locally brewed alcohol, noting that the market is largely unregulated and that some forms used by participants were reported to contain up to 90% alcohol. The researchers said the higher risk linked to local brews could be partly related to contamination with toxic substances such as methanol and acetaldehyde.

“In summary, our study demonstrates that there is no safe limit of alcohol consumption for [buccal mucosa cancer] risk…Our findings suggest that public health action towards prevention of alcohol and tobacco use could largely eliminate [buccal mucosa cancer] from India,” the authors concluded.

Ohun tí àwọn ènìyàn ń sọ

Discussions on X primarily consist of news outlets and medical professionals sharing the study's findings that even one daily standard drink increases buccal mucosa cancer risk by 50% in India, with higher risks from local brews and combination with chewing tobacco accounting for 62% of cases. Sentiments are mostly neutral warnings urging prevention, with minor skeptical humor.

Awọn iroyin ti o ni ibatan

Illustration showing U.S. adults enjoying moderate holiday drinks with subtle cancer risk warnings overlaid, highlighting a new study's findings.
Àwòrán tí AI ṣe

Review links even moderate alcohol use to higher cancer risk in U.S. adults

Ti AI ṣe iroyin Àwòrán tí AI ṣe Ti ṣayẹwo fun ododo

A new systematic review finds that even moderate alcohol consumption is associated with increased cancer risk, shaped by how often and how much people drink, as well as biological, behavioral and social factors. Researchers from Florida Atlantic University analyzed 62 studies of U.S. adults and highlighted how genetics, health conditions and socioeconomic status can amplify these dangers, underscoring the need for tailored prevention strategies during the holiday drinking season and beyond.

A new study tracking U.S. adults over two decades links heavy lifetime alcohol consumption to increased colorectal cancer risk, particularly for rectal cancer. Heavy drinkers faced up to a 95% higher risk compared to light drinkers, but former drinkers showed no elevated risk. The findings suggest quitting alcohol could reduce long-term cancer chances.

Ti AI ṣe iroyin Ti ṣayẹwo fun ododo

More than half of American adults do not realize alcohol raises cancer risk, and people who drink are the least aware, according to a research letter published October 30, 2025, in JAMA Oncology. The analysis, led by MD Anderson Cancer Center, draws on a national survey of nearly 7,000 adults and underscores the need for clearer public education.

A small study from researchers in India has found that a short course of an oral combination of resveratrol and copper was associated with reduced biological markers of aggressiveness in glioblastoma tumors, without reported side effects. Patients who took the nutraceutical before surgery showed lower levels of several key cancer-related markers in their tumor samples, and the approach targets harmful DNA-containing particles released from dying cancer cells.

Ti AI ṣe iroyin

Colombia's Health Ministry backs the VAT increase on alcohol and tobacco from 5% to 19%, arguing it will protect public health by curbing consumption and related deaths. However, up to 20 governors oppose it, claiming the measure violates territorial autonomy and cuts revenues for health and education. The government has called a meeting for January 19, 2026, in Bogotá to clarify Decree 1474 of 2025.

A new study reveals that chemotherapy's damage to the gut lining unexpectedly rewires the microbiota, producing a compound that strengthens immune defenses against cancer spread. This process reduces immunosuppressive cells and enhances resistance to metastasis, particularly in the liver. Patient data links higher levels of this compound to improved survival in colorectal cancer cases.

Ti AI ṣe iroyin

As South Africans recover from the 2025 festive season, liquor retailers reported record sales, but a rising segment of consumers turned to non-alcoholic options. This reveals a market dividing between heavy traditional drinkers and sober-curious alternators. The trends underscore shifting habits in a country with above-average alcohol consumption.

 

 

 

Ojú-ìwé yìí nlo kuki

A nlo kuki fun itupalẹ lati mu ilọsiwaju wa. Ka ìlànà àṣírí wa fun alaye siwaju sii.
Kọ